- Home
- ESQ vs QURE Comparison
ESQ vs QURE Comparison
Compare ESQ & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESQ | QURE |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 1.1B |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ESQ | QURE |
|---|---|---|
| Price | $122.11 | $40.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $120.33 | $45.00 |
| AVG Volume (30 Days) | 118.9K | ★ 2.9M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | 14.20 | ★ 29.67 |
| EPS | ★ 1.40 | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | $35.15 | $126.12 |
| Revenue Next Year | $39.09 | $200.43 |
| P/E Ratio | $88.12 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $90.57 | $8.73 |
| 52 Week High | $125.85 | $71.50 |
Technical Indicators
Market Signals| Indicator | ESQ | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 51.24 |
| Support Level | $103.79 | $39.50 |
| Resistance Level | $124.95 | $50.47 |
| Average True Range (ATR) | 3.47 | 2.42 |
| MACD | 0.11 | -1.14 |
| Stochastic Oscillator | 56.85 | 18.87 |
Price Performance
Historical ComparisonAbout ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.